Kamada (KMDA) Net Margin Growth (3y) (2015 - 2026)

Kamada (KMDA) Net Margin Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 3,662.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -98.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1,235.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 11,401.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4,252.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -404.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -15,806.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -987.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 3,232.00
10 Kamada 504.70 -73.15 Mn 19.12 Mn 913.00

Historic Data

Download Data
DateValue
Mar 31, 2026 913.00
Dec 31, 2025 674.00
Sep 30, 2025 1,796.00
Jun 30, 2025 1,662.00
Mar 31, 2025 2,755.00
Dec 31, 2024 2,458.00
Sep 30, 2024 1,333.00
Jun 30, 2024 -387.00
Mar 31, 2024 -413.00
Dec 31, 2023 872.00
Sep 30, 2023 -1,085.00
Jun 30, 2023 -554.00
Mar 31, 2023 -1,567.00
Dec 31, 2022 -1,024.00
Sep 30, 2022 -1,761.00
Jun 30, 2022 -1,664.00
Mar 31, 2022 -2,488.00
Dec 31, 2021 -5,163.00
Sep 30, 2021 1,230.00
Jun 30, 2021 385.00